Hyphens Pharma International Limited

Catalist:1J5 Stock Report

Market Cap: S$86.5m

Hyphens Pharma International Future Growth

Future criteria checks 1/6

Hyphens Pharma International is forecast to grow earnings and revenue by 6.2% and 3.4% per annum respectively. EPS is expected to grow by 5.9% per annum. Return on equity is forecast to be 14.9% in 3 years.

Key information

6.2%

Earnings growth rate

5.9%

EPS growth rate

Pharmaceuticals earnings growth16.9%
Revenue growth rate3.4%
Future return on equity14.9%
Analyst coverage

Low

Last updated13 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

Catalist:1J5 - Analysts future estimates and past financials data (SGD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262111210131
12/31/202520412982
12/31/2024195111142
6/30/20241961013N/A
3/31/202418510N/AN/AN/A
12/31/2023171946N/A
9/30/20231567N/AN/AN/A
6/30/20231569911N/A
3/31/202315610N/AN/AN/A
12/31/2022162111617N/A
9/30/202215612N/AN/AN/A
6/30/2022143978N/A
3/31/20221328N/AN/AN/A
12/31/2021126756N/A
9/30/20211266N/AN/AN/A
6/30/2021123667N/A
3/31/20211266N/AN/AN/A
12/31/2020121634N/A
9/30/2020126734N/A
6/30/2020125867N/A
3/31/2020124789N/A
12/31/2019119799N/A
9/30/20191176810N/A
6/30/20191155912N/A
3/31/20191175811N/A
12/31/2018121548N/A
9/30/2018117502N/A
6/30/2018117645N/A
3/31/20181156N/A3N/A
12/31/20171136N/A5N/A
12/31/20161015N/A6N/A
12/31/2015785N/A6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1J5's forecast earnings growth (6.2% per year) is above the savings rate (2.2%).

Earnings vs Market: 1J5's earnings (6.2% per year) are forecast to grow slower than the SG market (11.5% per year).

High Growth Earnings: 1J5's earnings are forecast to grow, but not significantly.

Revenue vs Market: 1J5's revenue (3.4% per year) is forecast to grow slower than the SG market (3.7% per year).

High Growth Revenue: 1J5's revenue (3.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 1J5's Return on Equity is forecast to be low in 3 years time (14.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y